Pilot Study of a Sedentary Behaviour Intervention for Individuals With a Spinal Cord Injury
REACH-SCI
Acceptability, Fidelity, Safety and Preliminary Efficacy of a Sedentary Behaviour Intervention in Individuals With Spinal Cord Injury: a Pilot Study
1 other identifier
interventional
20
1 country
1
Brief Summary
Individuals with spinal cord injury have a greater risk of heart disease and stroke than non-disabled individuals. This might be partly because wheelchair users engage in high amounts of sedentary behaviour. A review found a lack of programmes aimed at reducing sedentary behaviour in individuals with paraplegia. This means we do not know how good these programmes are for reducing heart disease risk markers. A programme to support reductions in sedentary behaviour has been co-designed with individuals with paraplegia, healthcare professionals, and people who support individuals with paraplegia in the community. This study aims to evaluate the new programme to determine its acceptability, fidelity, safety and preliminary efficacy. The Reducing sedEntary Activities to improve Cardiovascular Health in individuals with Spinal Cord Injury (REACH -SCI) intervention will last eight weeks and involve (1) a wearable activity tracker to give reminders to break up sedentary behaviour, (2) education around what sedentary behaviour is, how to reduce and break up sedentary behaviour, and the benefits of doing so, (3) a goal setting worksheet related to sedentary behaviour, (4) one-to-one motivational support sessions to help set goals, review progress and give motivation, (5) peer support using a group chat with other participants in a smartphone messaging app , and (6) activity tools (exercise bands and a handcycle) to support breaking up sedentary behaviour throughout the day. Measurements of fatigue, pain, physical activity, sedentary behaviour, heart disease risk markers, wellbeing, anxiety, depression and quality of life will be taken at baseline before the programme starts and then again after the programme ends. Acceptability of the intervention and data collection procedures will be explored using semi-structured interviews and questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2025
CompletedFirst Posted
Study publicly available on registry
May 4, 2025
CompletedStudy Start
First participant enrolled
May 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 22, 2025
September 1, 2025
8 months
April 23, 2025
September 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Intervention acceptability
Following completion of the intervention, acceptability will be assessed via an adapted questionnaire with 5-point Likert scales and individual semi-structured interviews to explore constructs from the Theoretical Framework of Acceptability (TFA). The TFA assesses acceptability in the context of seven components (affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness, and self-efficacy), as well as overall intervention acceptability.
At intervention end (8 weeks)
Intervention fidelity
Intervention fidelity will be assessed using a checklist to record each component being delivered as planned. This will include participants being provided with the wearable activity tracker, educational booklet, goal setting worksheet, exercise bands and portable hand cycle. Fidelity to the educational resource will be evaluated verbally in one-to-one motivational support sessions. Attendance at each motivational support session and duration of these sessions will be recorded. This will be in addition to a checklist for all planned aspects of the sessions being covered by the researcher delivering the intervention sessions.
From baseline to intervention end (8 weeks)
Intervention safety - Adverse events
Safety of the intervention will be evaluated through adverse events (AE) experienced during the study. These will be self-reported at each data collection point, during contact with a facilitator as part of the intervention, and ad-hoc throughout the study by contacting a member of the research team via phone or email.
From baseline to intervention end (8 weeks)
Intervention safety - Pain
Safety will also be evaluated by measuring pain using the McGill Pain Questionnaire (MPQ), which is validated in individuals with SCI. Pain will be rated across 20 domains of pain using rating scales. Overall pain will be scored from 0 to 78, with a higher score representing worse levels of pain.
Baseline and at intervention end (8 weeks)
Intervention safety - Fatigue
Safety will also be evaluated by measuring fatigue using the Modified Fatigue Impact Scale (MFIS), which is validated in individuals with SCI. Fatigue will be rated on a 5-point scale according to 21 domains of fatigue. Overall fatigue will be scored between 0 and 84, with a higher score representing worse levels of fatigue.
Baseline and at intervention end (8 weeks)
Secondary Outcomes (22)
Participant engagement
At intervention end (8 weeks)
Acceptability of data collection procedures
At intervention end (8 weeks)
Study feasibility
From recruitment to measurements taken at intervention end (8 weeks)
Sedentary time
Baseline and in the final week of the intervention period
Physical activity
Baseline and in the final week of the intervention period
- +17 more secondary outcomes
Study Arms (1)
Intervention
EXPERIMENTALAll participants will receive the REACH-SCI intervention in this single-arm study. The single arm will involve a wearable activity tracker, educational resources, goal setting, motivational support from a trained researcher, peer support and activity tools. The intervention period will be for eight weeks and will start after completion of all baseline measurements and provision of all intervention materials.
Interventions
The REACH-SCI intervention was co-designed with key stakeholders and aims to reduce and break up sedentary behaviour in individuals with paraplegia. The intervention will last eight weeks and involve (1) a wearable activity tracker to give reminders to break up sedentary behaviour, (2) education around what sedentary behaviour is, how to reduce and break up sedentary behaviour, and the benefits of doing so, (3) a goal setting worksheet related to sedentary behaviour, (4) one-to-one motivational support sessions to help set goals, review progress and give motivation, (5) peer support using a smartphone app, and (6) activity tools to support breaking up sedentary behaviour throughout the day.
Eligibility Criteria
You may qualify if:
- Individuals with self-reported paraplegia i.e. complete or incomplete SCI at T1 or below. Traumatic, non-traumatic, complete and incomplete SCI will all be eligible.
- At least 18 years of age.
- Self-report using a manual wheelchair as their primary mode of mobility inside and outside of the home.
- Able to travel to Brunel University of London to undertake study measurements.
- Access to use of a smartphone or tablet with internet access.
- Able to communicate in English at a level sufficient to understand the study, complete study measurements and engage fully with the intervention.
- Able to provide informed consent.
- Willing and able to provide fingertip blood samples and fast prior to measurement sessions.
- Able to independently transfer to a treatment couch and lay supine to undertake anthropometric measurements.
You may not qualify if:
- Self-reported heart condition, chest pain, dizziness, bone or joint problem, or any other condition that may be exacerbated by doing physical activity, as indicated via responses to the PAR-Q+.
- Self-reported history of uncontrolled autonomic dysreflexia in the past 12 months.
- Self-reported pregnancy.
- Currently participating in another research project that involves an intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brunel Universitylead
- Royal National Orthopaedic Hospital NHS Trustcollaborator
Study Sites (1)
Brunel University of London
Uxbridge, London, UB8 3PH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Bailey, PhD
Brunel University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Reader in Sedentary Behaviour and Health
Study Record Dates
First Submitted
April 23, 2025
First Posted
May 4, 2025
Study Start
May 12, 2025
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 22, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Shared data will be available at study end following data analysis, after which there will be no time limit to gain access.
- Access Criteria
- Shared, anonymised data will be publicly available in an online open research repository.
Raw, anonymised data will also be made publicly available in an open research repository to ensure transparency and reproducibility, but only including data from participants who consent to this. All data will be saved on a password-protected laptop and University server.